Sept. 21, 2015 – Despite widespread reports about the soaring prices of prescription drugs and calls by the federal government and members of Congress to lower these prices and break patents, the Center for Medicine in the Public Interest (CMPI) contends that it is time for a “careful examination of the rest of the story” […]
Read more